Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Research Reports

Microfluidics Market is expected to rise at a yearly growth rate of 6.0% Y-o-Y to $11.39 billion in 2032 | FMI

North America is expected to account for about 25.4% of the global microfluidics market. The high frequency and growth in incidence of various diseases, and government funding for the research and clinical testing by various institutions in the North America will assist market expansion.

NEWARK, Del: World demand for microfluidics is predicted to expand 6.0% year on year to $11.39 billion in 2032, driven by:

  • increased demand for POC testing, advancement of lab-on-a-chip technology, and development of point-of-care (POC) devices
  • the increased emphasis on data precision and accuracy
  • rapid testing and increased portability due to microfluidic chip downsizing
  • the creation of 3D cell culture systems based on microfluidics
  • the growing use of microfluidics in the health sciences and pharmaceutical sectors

The flow of liquids through various microscopic channels or mediums such as nozzles, pumps or chips is based on a technology known as microfluidics. The products based on such technology can control and direct the fluids at the lowest dimensions which could range from ten to hundreds of micrometers.

Microfluidics helps facilitate many assays concurrently. Thus, increasing the throughput where a good level of spatiotemporal control is possible. This reduces the consumption and cost of precious fluids, chemical and biological assays. Numerous applications utilizes microfluidics based technology such as clinical diagnostics, analytical testing, point-of-care testing and drug delivery. Genomics, proteomics and cell-based analysis uses microfluidics technology-based instruments and chips during analytical testing.

Request Sample@

List of Key Players Covered in Microfluidics Market are:

  • Thermo Fisher Scientific Inc
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • thinXXS Microtechnology

Microfluidics systems provides features such as ease of automation, reduction in the overall consumption of sample and reagents while reducing the analysis time. Thus, it can be considered as an attractive solution for various assays like chemical and biological assay. The system also allows to conduct assays parallel, thus decreasing the cost of the assays and time.

Microfluidics in 3D cell culture has recently enabled the development of microenvironments that facilitate differentiation of tissues and can also replicate the interface between 2 tissues. It can further facilitate spatiotemporal chemical gradients, as well as mechanical micro – environment of living organs. There is an ever-increasing demand for microfluidic lab-on-chip technology in the biomedical, pharmaceutical industries as well in anti-terrorism, environmental, food and military applications. To further add to this, the development of consumers, environmental and security markets, the speed, portability, availability and low costs of miniaturized biosensors have huge commercial potential.

Strategic collaborations among key players drive the microfluidics market to develop novel microfluidic platforms for drug discovery, portable diagnostic devices and others. The collaboration space is dominated by the players who have a strong product portfolio and patented technologies dedicated to clinical research and in-vitro diagnostics applications along with the local GMP certified manufacturing facilities.

In order to overcome difficulties associated with the fabrication included into the microfluidics devices, many companies are substituting the mixers in these devices with the bubbles at large. This can be the opportunity to improve the efficiency of the microfluidics devices creating a huge opportunity in the market.

Ask an Analyst@

Key Takeaways from Microfluidics Study

  • The ceramics segment is anticipated to hold the maximum share of 39.9% in 2022, expanding at 13.0% CAGR during the forecast period. Ceramics’ superior chemical resistivity, flexibility, and strength make them ideal for producing microfluidics devices, as seen by their significant market share.
  • The point of care testing segment is projected to account for 32.6% of the total market share in 2022 by application. In the fields of genomics and proteomics, point-of-care testing devices offer a lot of potential. These devices, for example, aid in the identification of the DNA of bacteria that cause various diseases and are also employed in protein analysis.
  • In-vitro diagnostics and life science research together hold over 53% of the market in 2022 and this trend is expected to continue during the forecast period as well. The growing number of experiment carried out in life science research using microfluidics is rising. This is propelling the sector forward. Aside from that, with increasing diseases, is increasing the in-vitro diagnostics demand.
  • North America is expected to account for about 25.4% of the global microfluidics market. The high frequency and growth in incidence of various diseases, and government funding for the research and clinical testing by various institutions in the North America will assist market expansion.

Who is winning?

The key market players covered by FMI include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Abbott Laboratories, Bio-Rad Laboratories, Inc., Qiagen NV, SCHOTT AG and thinXXS Microtechnology.

Some of the leading manufacturers of the microfluidics market are focusing on the development of advanced and cost-effective products and undertaking acquisitions to increase global presence.

  • In October 2021, Thermo Fisher Scientific Charts Digital PCR expansion after Combinati acquisition.
  • In November 2019, MicroMedicine, Inc., launched the Sorterra Cell Isolation System, an automated, microfluidics-based cell isolation technology at the Society for Immunotherapy of Cancer (SITC) Meeting.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global microfluidics market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on microfluidics market segment based on material (polymer {polyvinyl chloride (PVC) non-polyvinyl chloride}, glass, silicon, metal and ceramics), application (point of care testing, clinical diagnostics, drug delivery and analytical testing {genomics, proteomics, cell based analysis and others}), and industry (pharmaceuticals, in-vitro diagnostics, environmental research, life science research, clinical diagnostics) across seven major regions.

View Complete Report@

Detailed Table of Content:

  • Executive Summary
    • Global Market Outlook
    • Demand Side Trends
    • Supply Side Trends
    • Analysis and Recommendations
  • Market Overview
    • Market Coverage / Taxonomy
    • Market Definition / Scope / Limitations
  • Key Market Trends
    • Key Trends Impacting the Market
    • Innovation / Key Development Trends
    • New Launches / Approvals
  • Market Background
    • Macro-Economic Factors
      • Global GDP Growth Outlook
      • Global Healthcare Expenditure Outlook
      • Emerging Countries Healthcare and Development Outlook
    • Forecast Factors – Relevance & Impact
      • Adoption of Microfluidics
      • Historical growth of key players
      • New product launches and approvals
      • COVID-19 Impact
      • Expansion by Leading Manufacturer in Emerging Geographies
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunity Analysis
  • Market Context
    • List of Manufacturer and Supplier
    • Usage/ Adoption Analysis
    • Promotional Strategies by Key Manufacturer
    • Technological Advancements
    • Regulatory Scenario
    • Porter’s Analysis
    • PESTLE Analysis

Buy Now@

Have a Look at Related Reports of Healthcare domain

Cervical Dysplasia Treatment Market Size: Holding a value of US$ 978.3 Million from 2022-2032, the global cervical dysplasia market is expected to exhibit a CAGR of 4.4%. The market is projected to secure US$ 612.2 Million in 2022.

Cervical Spacer Systems Market Share: In 2022, the global cervical spacer systems market is expected to be worth US$ 361 Million. By 2032, the market is expected to grow to US$ 744.1 Million.

Home Sleep Apnea Testing Market Demand: The home sleep apnea testing market is likely to register a CAGR of 14.4% during the forecast period, and is anticipated to reach a market share of US$ 3.09 Bn in 2032, from US$ 0.70 Bn in 2021, owing to the increasing prevalence of sleep apnea throughout the globe.

Pipette controller Market Growth: Global pipette controller demand is anticipated to be valued at US$ 190 Million in 2022, forecast to grow at a CAGR of 4.6% to be valued at US$ 300 Million from 2022 to 2032.

Psychotropic Drugs Market Overview: The global psychotropic drugs market is estimated to exhibit growth at a CAGR of around 6% to 7% over the forecast period 2022-2032.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the UK, US, and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

LinkedInTwitterBlogs | YouTube
For Sales Enquiries: [email protected]

Global Banking & Finance Review


Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!

By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post